Royal Bank of Canada’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
2,440
| – | – | ﹤0.01% | 6321 |
|
|
2025
Q1 | $4K | Sell |
2,440
-22,789
| -90% | -$37.4K | ﹤0.01% | 6052 |
|
|
2024
Q4 | $84K | Buy |
25,229
+22,789
| +934% | +$75.9K | ﹤0.01% | 4973 |
|
|
2024
Q3 | $5K | Sell |
2,440
-2,016
| -45% | -$4.13K | ﹤0.01% | 6048 |
|
|
2024
Q2 | $9K | Sell |
4,456
-170,916
| -97% | -$345K | ﹤0.01% | 6007 |
|
|
2024
Q1 | $538K | Buy |
175,372
+174,107
| +13,763% | +$534K | ﹤0.01% | 3523 |
|
|
2023
Q4 | $3K | Sell |
1,265
-930
| -42% | -$2.21K | ﹤0.01% | 6212 |
|
|
2023
Q3 | $9K | Buy |
2,195
+788
| +56% | +$3.23K | ﹤0.01% | 5974 |
|
|
2023
Q2 | $6K | Buy |
1,407
+1,195
| +564% | +$5.1K | ﹤0.01% | 6178 |
|
|
2023
Q1 | $1K | Buy |
212
+169
| +393% | +$797 | ﹤0.01% | 6552 |
|
|
2022
Q4 | $0 | Buy |
43
+7
| +19% | – | ﹤0.01% | 7198 |
|
|
2022
Q3 | $0 | Buy |
36
+35
| +3,500% | – | ﹤0.01% | 7331 |
|
|
2022
Q2 | $0 | Sell |
1
-19
| -95% | – | ﹤0.01% | 7167 |
|
|
2022
Q1 | $0 | Sell |
20
-22
| -52% | – | ﹤0.01% | 7422 |
|
|
2021
Q4 | $1K | Sell |
42
-25
| -37% | -$595 | ﹤0.01% | 7008 |
|
|
2021
Q3 | $1K | Sell |
67
-143
| -68% | -$2.13K | ﹤0.01% | 6983 |
|
|
2021
Q2 | $13K | Buy |
210
+12
| +6% | +$743 | ﹤0.01% | 6273 |
|
|
2021
Q1 | $24K | Sell |
198
-63
| -24% | -$7.64K | ﹤0.01% | 5831 |
|
|
2020
Q4 | $30K | Buy |
261
+191
| +273% | +$22K | ﹤0.01% | 5336 |
|
|
2020
Q3 | $8K | Sell |
70
-6
| -8% | -$686 | ﹤0.01% | 5524 |
|
|
2020
Q2 | $10K | Sell |
76
-7
| -8% | -$921 | ﹤0.01% | 5365 |
|
|
2020
Q1 | $16K | Buy |
83
+65
| +361% | +$12.5K | ﹤0.01% | 5146 |
|
|
2019
Q4 | $6K | Buy |
18
+15
| +500% | +$5K | ﹤0.01% | 5707 |
|
|
2019
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 5844 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | -$1K | – | 5948 |
|
|
2018
Q4 | $1K | Sell |
3
-6
| -67% | -$2K | ﹤0.01% | 5699 |
|
|
2018
Q3 | $7K | Sell |
9
-94
| -91% | -$73.1K | ﹤0.01% | 5520 |
|
|
2018
Q2 | $60K | Buy |
103
+100
| +3,333% | +$58.3K | ﹤0.01% | 4497 |
|
|
2018
Q1 | $7K | Buy |
+3
| New | +$7K | ﹤0.01% | 5238 |
|